SEARCH

SEARCH BY CITATION

References

  • 1
    Holmes NE, Turnidge JD, Munckhof WJ et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011; 204: 340347.
  • 2
    Holland TL, Fowler VG Jr. Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet? J Infect Dis 2011; 204: 329331.
  • 3
    Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 14181423.
  • 4
    Lesens O, Methlin C, Hansmann Y et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003; 24: 890896.
  • 5
    Paterson DL, Ko WC, Von Gottberg A et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 2632.
  • 6
    Fowler VG Jr, Justice A, Moore C et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005; 40: 695703.
  • 7
    Bader MS. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain. Infect Control Hosp Epidemiol 2006; 27: 12191225.
  • 8
    Chang FY, MacDonald BB, Peacock JE Jr et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003; 82: 322332.
  • 9
    Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard-seventh edition. CLSI document M07-A7. Wayne, PA, USA: CLSI, 2006.
  • 10
    Van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012; 54: 755771.
  • 11
    Price J, Atkinson S, Llewelyn M, Paul J. Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin. Clin Infect Dis 2009; 48: 997998.
  • 12
    Edwards B, Milne K, Lawes T, Cook I, Robb A, Gould IM. Is vancomycin MIC “creep” method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from north east Scotland from 2006 to 2010. J Clin Microbiol 2012; 50: 318325.
  • 13
    Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e1855.
  • 14
    Rybak M, Lomaestro B, Rotschafer JC et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66: 8298.
  • 15
    Shepardson LB, Youngner SJ, Speroff T, O'Brien RG, Smyth KA, Rosenthal GE. Variation in the use of do-not-resuscitate orders in patients with stroke. Arch Intern Med 1997; 157: 18411847.
  • 16
    Wenger NS, Pearson ML, Desmond KA et al. Epidemiology of do-not-resuscitate orders. Disparity by age, diagnosis, gender, race, and functional impairment. Arch Intern Med 1995; 155: 20562062.
  • 17
    Aguado JM, San Juan R, Lalueza A et al. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteraemia. Emerg Infect Dis 2011; 17: 10991102.
  • 18
    Wertheim HF, Van Leeuwen WB, Snijders S et al. Associations between Staphylococcus aureus genotype, infection, and in-hospital mortality: a nested case–control study. J Infect Dis 2005; 192: 11961200.
  • 19
    Lalani T, Federspiel JJ, Boucher HW et al. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol 2008; 46: 28902896.
  • 20
    Holmes NE, Turnidge JD, Munckhof WL et al. Organism factors associated with elevated vancomycin minimum inhibitory concentration (MIC) in Staphylococcus aureus bacteraemia. In: Program and abstracts of the 15th International Symposium on Staphylococci and Staphylococcal Infections. Lyon, France, 2012.
  • 21
    Miller CE, Batra R, Cooper BS et al. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. Clin Infect Dis 2012; 54: 591600.